Pregled bibliografske jedinice broj: 1059182
Ret expression and its correlation with clinicopathologic data in papillary thyroid carcinoma
Ret expression and its correlation with clinicopathologic data in papillary thyroid carcinoma // Acta Clinica Croatica, 57 (2018), 4; 646-652 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1059182 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Ret expression and its correlation with
clinicopathologic data in papillary thyroid carcinoma
Autori
Punda, Ante ; Bedeković, Vladimir ; Barić, Ana ; Kontić, Mirko ; Čolović, Zaviša ; Vanjaka Rogošić, Lucija ; Punda, Hrvoje ; Kunac, Nenad ; Grandić, Leo ; Pešutić Pisac, Valdi
Izvornik
Acta Clinica Croatica (0353-9466) 57
(2018), 4;
646-652
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
RET expression ; papillary thyroid carcinoma
Sažetak
The purpose of this study was to analyze the possible prognostic value of RET mutation in papillary thyroid carcinoma and its incidence in the past few decades in our population, due to the increasing incidence of papillary thyroid carcinoma. The present study included 180 patients operated for papillary thyroid carcinoma. The clinical and histopathologic characteristics were analyzed. Paraffin sections of the selected histologic slides were cut again and immunohistochemically stained by the Clone 3F8 P (HIER) from Novocastra (Vision Bio Systems Europe, Newcastle upon Tyne, UK) monoclonal antibody to RET oncoprotein. Univariate analysis indicated sex (p=0.01), histologic subtype (p=0.075) and capsular invasion (p=0.010) to be statistically significant predictors of lymph node metastases, whereas age (p=0.796), tumor size (p=0.556) and intraglandular dissemination (p=0.131) showed no such correlation. The presence of RET mutation (p=0.704) was not a statistically significant predictor of the tumor metastasizing potential. RET mutation (p=0.500) showed no statistically significant correlation with papillary thyroid carcinoma classifed into prognostic groups according to clinicopathologic features either. RET mutation was detected in 30% of 180 papillary thyroid carcinomas. This is the first large study demonstrating that RET mutation incidence in papillary thyroid carcinoma in Croatian population is consistent with the classic distribution of sporadic cases, despite the increased prevalence of papillary thyroid carcinoma in the past few decades.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
KBC Split,
Medicinski fakultet, Split
Profili:
Mirko Kontić
(autor)
Vladimir Bedeković
(autor)
Nenad Kunac
(autor)
Valdi Pešutić-Pisac
(autor)
Ana Barić Žižić
(autor)
Lucija Vanjaka Rogošić
(autor)
Ante Punda
(autor)
Leo Grandić
(autor)
Zaviša Čolović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE